Unknown

Dataset Information

NF-κB inhibitor, NEMO-binding domain peptide attenuates intervertebral disc degeneration.


ABSTRACT:

Background context

Nonphysiological mechanical loading and inflammation are both critically involved in intervertebral disc (IVD) degeneration, which is characterized by an increase in cytokines and matrix metalloproteases (MMPs) in the nucleus pulposus (NP). This process is known to be mediated by the NF-κB pathway.

Clinical significance

Current clinical treatments for IVD degeneration focus on the alleviation of symptoms rather than targeting the underlying mechanism. Injection of an NF-κB inhibitor may attenuate the progression of IVD degeneration.

Purpose

To investigate the ability of the NF-κB inhibitor, NEMO binding domain peptide (NBD), to alter IVD degeneration processes by reducing IL-1β- and mechanically-induced cytokine and MMP levels in human nucleus pulpo

SUBMITTER: Glaeser JD 

PROVIDER: S-EPMC7494571 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature